You are here

• Home
• About AstraZeneca US
• Newsroom

• Product news

The following shows headlines of all product-related news articles published within 12-months, starting from most recent.

• Pages
• 1
• 2
• 3
• 4
• Next

• • May 10, 2012
  • SYMBICORT® (budesonide/formoterol fumarate dihydrate) long-term study shows similar safety profile when compared to budesonide monotherapy in African-American patients with asthma  
• • May 1, 2012
  • LUNAR examines cholesterol-lowering effects of CRESTOR® (rosuvastatin calcium) compared with atorvastatin in patients with acute coronary syndrome  
• • Apr 27, 2012
  • AstraZeneca marks 30 years of supporting women with metastatic breast cancer  
• • Apr 12, 2012
  • AstraZeneca launches DUTOPROL™ (metoprolol succinate extended release/hydrochlorothiazide) tablets for high blood pressure in U.S.  
• • Mar 30, 2012
  • US District Court finds SEROQUEL XR formulation patent valid and infringed  
• • Mar 26, 2012
  • US court denies preliminary injunction application against the FDA and dismisses AstraZeneca’s lawsuit without prejudice  
• • Mar 25, 2012
  • New data suggests results of PLATO genetic sub-study outcomes for BRILINTA® (ticagrelor) not driven by poor metabolizers of clopidogrel  
• • Mar 25, 2012
  • New data suggests BRILINTA® (ticagrelor) reduced first and recurrent cardiovascular and ischemic events  
• • Mar 22, 2012
  • AstraZeneca announces increased coverage of BRILINTA® (ticagrelor) through plan preferred formulary status on Medco Health Solutions  
• • Mar 13, 2012
  • AstraZeneca files lawsuit against the FDA for decision regarding quetiapine product labeling and exclusivity  

• Pages
• 1
• 2
• 3
• 4
• Next

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed